Deepak Kilari
Deepak Kilari
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Zanzalintinib in Men With Aggressive Variant Prostate Cancer | Aggressive Variant Prostate Carcinoma | Recruiting | Phase 2 | 2026-08-28 | NCT07218666 | |
| Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Active, not recruiting | Phase 2 | 2024-12-04 | NCT04289779 |